These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 19326288

  • 21. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
    Srinivasan V, Zakaria R, Othaman Z, Brzezinski A, Prasad A, Brown GM.
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
    [Abstract] [Full Text] [Related]

  • 22. Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.
    Yukuhiro N, Kimura H, Nishikawa H, Ohkawa S, Yoshikubo S, Miyamoto M.
    Brain Res; 2004 Nov 19; 1027(1-2):59-66. PubMed ID: 15494157
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Agomelatine in depressive disorders: its novel mechanisms of action.
    Srinivasan V, Zakaria R, Othman Z, Lauterbach EC, Acuña-Castroviejo D.
    J Neuropsychiatry Clin Neurosci; 2012 Nov 19; 24(3):290-308. PubMed ID: 23037643
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Lights off? Neurobiological and pharmacological aspects of the melatonergic-serotonergic synergism].
    Sumegi A, Somoskovi C.
    Neuropsychopharmacol Hung; 2010 Dec 19; 12(4):469-75. PubMed ID: 21220792
    [Abstract] [Full Text] [Related]

  • 28. [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Steinhilber D.
    Pharm Unserer Zeit; 2007 Dec 19; 36(3):213-7. PubMed ID: 17555058
    [No Abstract] [Full Text] [Related]

  • 29. Agomelatine, melatonin and depressive disorder.
    Norman TR.
    Expert Opin Investig Drugs; 2013 Apr 19; 22(4):407-10. PubMed ID: 23484857
    [Abstract] [Full Text] [Related]

  • 30. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM.
    Prog Neurobiol; 2009 Aug 19; 88(4):264-71. PubMed ID: 19454302
    [Abstract] [Full Text] [Related]

  • 31. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders.
    Rivara S, Mor M, Bedini A, Spadoni G, Tarzia G.
    Curr Top Med Chem; 2008 Aug 19; 8(11):954-68. PubMed ID: 18673165
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic potential of agomelatine in epilepsy and epileptic complications.
    Vimala PV, Bhutada PS, Patel FR.
    Med Hypotheses; 2014 Jan 19; 82(1):105-10. PubMed ID: 24314750
    [Abstract] [Full Text] [Related]

  • 33. Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.
    Catena-Dell'Osso M, Marazziti D, Rotella F, Bellantuono C.
    Curr Med Chem; 2012 Jan 19; 19(3):428-37. PubMed ID: 22335516
    [Abstract] [Full Text] [Related]

  • 34. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.
    Tchekalarova J, Kortenska L, Ivanova N, Atanasova M, Marinov P.
    Psychopharmacology (Berl); 2020 Feb 19; 237(2):503-518. PubMed ID: 31720718
    [Abstract] [Full Text] [Related]

  • 35. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 19; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 36. Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep.
    Markwald RR, Lee-Chiong TL, Burke TM, Snider JA, Wright KP.
    Sleep; 2010 Jun 19; 33(6):825-31. PubMed ID: 20550024
    [Abstract] [Full Text] [Related]

  • 37. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP, McLin DE, Dressman MA, Neubauer DN.
    Pharmacotherapy; 2016 Sep 19; 36(9):1028-41. PubMed ID: 27500861
    [Abstract] [Full Text] [Related]

  • 38. The interaction between the internal clock and antidepressant efficacy.
    Racagni G, Riva MA, Popoli M.
    Int Clin Psychopharmacol; 2007 Oct 19; 22 Suppl 2():S9-S14. PubMed ID: 17917564
    [Abstract] [Full Text] [Related]

  • 39. The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.
    Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    World J Biol Psychiatry; 2009 Oct 19; 10(4 Pt 2):342-54. PubMed ID: 18609422
    [Abstract] [Full Text] [Related]

  • 40. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimura N.
    Sleep Med; 2011 Feb 19; 12(2):127-33. PubMed ID: 21277255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.